NEW YORK (GenomeWeb) – Chinese molecular diagnostics firm Burning Rock said today that it has closed a Series C financing totaling RMB 850 million (US$126 million). The round was led by GIC, followed by LYFE Capital, CMB International Capital, Lilly Asia Ventures, Sequoia Capital China, and T&Brothers Capital.
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.